aid: abbisko
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abbisko.png
name: abbisko
description: Abbisko Therapeutics (上海和誉生物医药科技有限公司) is a Shanghai-based clinical-stage
  biopharmaceutical company focused on the discovery and development of innovative small-molecule
  therapeutics, primarily in oncology. It was surfaced as a portfolio company of Qiming Venture
  Partners and added to the API Evangelist network as a stub. Enrichment found no public developer
  API, SDK, documentation, or agent surface — this is a biopharmaceutical R&D company, not an API
  provider — so no API artifacts apply; only a live domain-security probe was captured.
url: https://raw.githubusercontent.com/api-evangelist/abbisko/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
x-no-api-surface: true
tags:
- Company
- Biopharmaceutical
- Oncology
- Drug Discovery
- Small Molecule
- Healthcare
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abbisko-domain-security.yml
- type: Website
  url: https://abbisko.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence